Skye Bioscience, Inc Common Stock (SKYE) had the highest return between September 1, 2014 and August 1, 2015 by a US stock, returning 65,894.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Skye Bioscience, Inc Common Stock (SKYE) | 9/1/2014 - 8/1/2015 | 65,894.72% |
OLB (OLB) | 9/1/2014 - 8/1/2015 | 1,180% |
Nutex Health (NUTX) | 9/1/2014 - 8/1/2015 | 900% |
Patriot National Bancorp (PNBK) | 9/1/2014 - 8/1/2015 | 842.97% |
Ainos (AIMD) | 9/1/2014 - 8/1/2015 | 636.84% |
INVO Fertility (IVF) | 9/1/2014 - 8/1/2015 | 603.13% |
Focus Universal (FCUV) | 9/1/2014 - 8/1/2015 | 500% |
Atara Biotherapeutics (ATRA) | 9/1/2014 - 8/1/2015 | 467.64% |
GreenPro Capital (GRNQ) | 9/1/2014 - 8/1/2015 | 414.29% |
GEE (JOB) | 9/1/2014 - 8/1/2015 | 350% |
Fluent (FLNT) | 9/1/2014 - 8/1/2015 | 344.46% |
Celsius (CELH) | 9/1/2014 - 8/1/2015 | 324.64% |
Alaunos Therapeutics (TCRT) | 9/1/2014 - 8/1/2015 | 313.62% |
FiEE (FIEE) | 9/1/2014 - 8/1/2015 | 290.48% |
eXp World (AGNT) | 9/1/2014 - 8/1/2015 | 267.32% |
Lakefront Biotherapeutics (LKFT) | 9/1/2014 - 8/1/2015 | 266.82% |
Anavex Life Sciences (AVXL) | 9/1/2014 - 8/1/2015 | 264.04% |
Heron Therapeuti (HRTX) | 9/1/2014 - 8/1/2015 | 244.41% |
Precigen (PGEN) | 9/1/2014 - 8/1/2015 | 238.15% |
Ambarella (AMBA) | 9/1/2014 - 8/1/2015 | 235.86% |
Neurocrine Biosciences (NBIX) | 9/1/2014 - 8/1/2015 | 203.02% |
Exelixis (EXEL) | 9/1/2014 - 8/1/2015 | 198.44% |
Prothena (PRTA) | 9/1/2014 - 8/1/2015 | 185.09% |
Digitalbridge (DBRG) | 9/1/2014 - 8/1/2015 | 180% |
Coherus BioSciences (CHRS) | 9/1/2014 - 8/1/2015 | 175.14% |